Cargando…

Effect of Coronavirus Disease 2019 Vaccine-Related Lymphadenopathy on Lung Cancer Treatment

Detalles Bibliográficos
Autores principales:	Masago, Katsuhiro, Fujita, Shiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678031/ https://www.ncbi.nlm.nih.gov/pubmed/34930606 http://dx.doi.org/10.1016/j.jtho.2021.10.002

Ejemplares similares

Alteration of DNA mismatch repair capacity underlying the co-occurrence of non-small-cell lung cancer and nonmedullary thyroid cancer
por: Fujita, Shiro, et al.
Publicado: (2021)

COVID-19 Vaccination-Related Lymphadenopathy: What To Be Aware Of
por: Tu, Wendy, et al.
Publicado: (2021)

Deep axillary lymphadenopathy after coronavirus disease 2019 vaccination: a case report
por: Mori, Mio, et al.
Publicado: (2021)

Biopsy of palliative lesions following radiotherapy
por: Fujita, Shiro, et al.
Publicado: (2019)

Mediastinal Lymphadenopathy in Interstitial Lung Disease. Time to Be Counted
por: Walsh, Simon L. F.
Publicado: (2019)

Cough, coronavirus disease 2019, the vaccines, and allergy
por: Chang, Yoon-Seok
Publicado: (2021)

Comparison between Fluorimetry (Qubit) and Spectrophotometry (NanoDrop) in the Quantification of DNA and RNA Extracted from Frozen and FFPE Tissues from Lung Cancer Patients: A Real-World Use of Genomic Tests
por: Masago, Katsuhiro, et al.
Publicado: (2021)

Surgical treatment of lung cancer during the coronavirus disease 2019 (COVID-19) pandemic: lessons learned
por: Carretta, Angelo
Publicado: (2022)

Coronavirus-vaccine: Supraclavicular lymphadenopathy: 2 case reports
Publicado: (2022)

Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging Characteristics
por: Nishino, Mizuki, et al.
Publicado: (2022)

Outcome of Surgical Treatment for Metastatic Vertebra Bone Tumor in Advanced Lung Cancer
por: Fukuhara, Akiko, et al.
Publicado: (2010)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
por: Sasaki, Eiichi, et al.
Publicado: (2020)

New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019
por: Zhang, Chao, et al.
Publicado: (2022)

Coronavirus Disease 2019 Treatment: It is Time for Stewardship!
por: Nasa, Prashant
Publicado: (2020)

Targeted RNA sequencing with touch imprint cytology samples for non‐small cell lung cancer patients
por: Seto, Katsutoshi, et al.
Publicado: (2020)

Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer
por: Fujita, Shiro, et al.
Publicado: (2015)

Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing?
por: Greenhawt, Matthew
Publicado: (2022)

Engaging Nursing Assistants to Enhance Receptivity to the Coronavirus Disease 2019 Vaccine
por: Sadarangani, Tina R., et al.
Publicado: (2021)

Effects of nonpharmaceutical interventions for coronavirus disease 2019
por: Choi, Jae Hong
Publicado: (2022)

Is type 1 diabetes related to coronavirus disease 2019 in children?
por: Kim, Minsun
Publicado: (2022)

Long-Term Recurrence of Completely Resected NSCLC
por: Masago, Katsuhiro, et al.
Publicado: (2020)

Coronavirus Disease 2019 and Stroke
por: Kim, Jong S.
Publicado: (2020)

Challenges of coronavirus disease 2019
por: The Lancet Infectious Diseases
Publicado: (2020)

Surgical perception of lower tracheal or carinal resection
por: Sugita, Yusuke, et al.
Publicado: (2021)

Coronavirus disease 2019 and mRNA vaccines: what’s next – miRNA?
por: Lee, Joon Kee, et al.
Publicado: (2022)

Customized chemotherapy based on epidermal growth factor receptor mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
por: Fujita, Shiro, et al.
Publicado: (2012)

Feasibility of coronavirus disease 2019 eradication
por: Zheng, Ya-Li, et al.
Publicado: (2020)

Arterial Thrombosis and Coronavirus Disease 2019
por: McBane, Robert D.
Publicado: (2021)

Engel in the Time of Coronavirus Disease 2019
por: Davidson, John H.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19)
por: Goldust, Mohamad
Publicado: (2022)

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer
por: Kagawa, Yusuke, et al.
Publicado: (2020)

Lung transplantation and coronavirus disease 2019 (COVID-19): a roadmap for the enduring pandemic
por: Shigemura, Norihisa, et al.
Publicado: (2021)

The role of traditional Chinese medicine in the prevention and treatment of coronavirus disease 2019
por: Yao, Chensi, et al.
Publicado: (2022)

Programmed death-ligand 1 expression according to epidermal growth factor receptor mutation status in pretreated non-small cell lung cancer
por: Hata, Akito, et al.
Publicado: (2017)

Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy
por: Fujita, Shiro, et al.
Publicado: (2010)

Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations
por: Masago, Katsuhiro, et al.
Publicado: (2015)

Single nucleotide variant sequencing errors in whole exome sequencing using the Ion Proton System
por: Fujita, Shiro, et al.
Publicado: (2017)

The beginning of a new era in induction treatment for operable non-small cell lung cancer: a narrative review
por: Shinohara, Shuichi, et al.
Publicado: (2023)

Social stigma in the time of coronavirus disease 2019
por: Sotgiu, Giovanni, et al.
Publicado: (2020)

Immunotherapy and Coronavirus Disease 2019: Challenges and Possibilities
por: Bakhribah, Hatoon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tjqgflkrdrp8ig9p6hdfvemrv0